Manager Dashboard
Portfolio Overview
Study: Post-Market Clinical Follow-Up Study of the VascuPath 3F Interventional Catheter
Protocol: PMCF-2024-CAT-001 | Status: Active | Device: VascuPath 3F Interventional Catheter (Class IIb)
Overall enrollment: 94 / 120 (78%)
Overdue Escalations
2 overdue item(s) requiring escalation
SAE SAE-001 at Site 04 — Hamburg —
Day 74 of 15 — 0 day(s) overdue
COMPLAINT SAE-002 at Site 07 — Lyon —
Day 63 of 15 — 0 day(s) overdue
Total Sites
8
8 active
Open SAEs
2
2 overdue
Open Communications
3
3 pending review
Silent Sites
8
Exceeding contact threshold
CRA Performance
| CRA | Sites Assigned | Open Items | Overdue Items | Last Activity |
|---|---|---|---|---|
| Sarah Mitchell | 8 | 3 | 2 | 14 Mar 2026 08:30 |
Site Portfolio
| Site # | City | Country | PI | Enrolled | Last Contact | Flags | Actions |
|---|---|---|---|---|---|---|---|
| 01 | Brussels | BE | Dr. Elise Van den Berg | 14/15 | 12 Mar 2026 | SILENT | View |
| 02 | Amsterdam | NL | Dr. Pieter Hoekstra | 11/15 | 20 Feb 2026 | SILENT | View |
| 03 | Barcelona | ES | Dr. Carmen Fernández | 13/15 | 10 Mar 2026 | SILENT | View |
| 04 | Hamburg | DE | Dr. Friedrich Richter | 12/15 | 01 Mar 2026 | OVERDUE SAE SILENT | View |
| 05 | Vienna | AT | Dr. Stefan Gruber | 10/15 | 07 Mar 2026 | SILENT | View |
| 06 | Milan | IT | Dr. Marco Conti | 12/15 | 14 Mar 2026 | SILENT | View |
| 07 | Lyon | FR | Dr. Isabelle Lefebvre | 11/15 | 13 Mar 2026 | OVERDUE SAE SILENT | View |
| 08 | Warsaw | PL | Dr. Tomasz Kowalski | 11/15 | 09 Mar 2026 | SILENT | View |